. | All patients . | Women . | Men . | P-valuea . |
---|---|---|---|---|
MoCA score | ||||
Baseline | 27 (25–29) n = 618 | 27 (24, 29) n = 206 | 27 (25, 29) n = 412 | 0.54 |
Follow-up | 28 (26–29) n = 607 | 28 (26–29) n = 204 | 28 (26–29) n = 403 | 0.57 |
Change | ||||
Absolute, median (q1–q3) | 1 (−1 to 2) | 1 (−1 to 2) | 0 (−1 to 2) | 0.37 |
Percentage, median (q1–q3) | 3.4 (−3.4 to 7.7) n = 597 | 3.4 (−3.3 to 8.2) n = 201 | 0 (−3.4 to 7.4) n = 396 | |
P-valueb | <0.001 | <0.001 | <0.001 | |
At least mild cognitive impairment (MoCA < 26) | ||||
Baseline | 188 (30) n = 618 | 65 (32) n = 206 | 123 (30) n = 412 | 0.71 |
Follow-up | 141 (23) n = 607 | 47 (23) n = 204 | 94 (23) n = 403 | 0.99 |
P-value | <0.001 | <0.001 | <0.001 |
. | All patients . | Women . | Men . | P-valuea . |
---|---|---|---|---|
MoCA score | ||||
Baseline | 27 (25–29) n = 618 | 27 (24, 29) n = 206 | 27 (25, 29) n = 412 | 0.54 |
Follow-up | 28 (26–29) n = 607 | 28 (26–29) n = 204 | 28 (26–29) n = 403 | 0.57 |
Change | ||||
Absolute, median (q1–q3) | 1 (−1 to 2) | 1 (−1 to 2) | 0 (−1 to 2) | 0.37 |
Percentage, median (q1–q3) | 3.4 (−3.4 to 7.7) n = 597 | 3.4 (−3.3 to 8.2) n = 201 | 0 (−3.4 to 7.4) n = 396 | |
P-valueb | <0.001 | <0.001 | <0.001 | |
At least mild cognitive impairment (MoCA < 26) | ||||
Baseline | 188 (30) n = 618 | 65 (32) n = 206 | 123 (30) n = 412 | 0.71 |
Follow-up | 141 (23) n = 607 | 47 (23) n = 204 | 94 (23) n = 403 | 0.99 |
P-value | <0.001 | <0.001 | <0.001 |
. | All patients . | Women . | Men . | P-valuea . |
---|---|---|---|---|
MoCA score | ||||
Baseline | 27 (25–29) n = 618 | 27 (24, 29) n = 206 | 27 (25, 29) n = 412 | 0.54 |
Follow-up | 28 (26–29) n = 607 | 28 (26–29) n = 204 | 28 (26–29) n = 403 | 0.57 |
Change | ||||
Absolute, median (q1–q3) | 1 (−1 to 2) | 1 (−1 to 2) | 0 (−1 to 2) | 0.37 |
Percentage, median (q1–q3) | 3.4 (−3.4 to 7.7) n = 597 | 3.4 (−3.3 to 8.2) n = 201 | 0 (−3.4 to 7.4) n = 396 | |
P-valueb | <0.001 | <0.001 | <0.001 | |
At least mild cognitive impairment (MoCA < 26) | ||||
Baseline | 188 (30) n = 618 | 65 (32) n = 206 | 123 (30) n = 412 | 0.71 |
Follow-up | 141 (23) n = 607 | 47 (23) n = 204 | 94 (23) n = 403 | 0.99 |
P-value | <0.001 | <0.001 | <0.001 |
. | All patients . | Women . | Men . | P-valuea . |
---|---|---|---|---|
MoCA score | ||||
Baseline | 27 (25–29) n = 618 | 27 (24, 29) n = 206 | 27 (25, 29) n = 412 | 0.54 |
Follow-up | 28 (26–29) n = 607 | 28 (26–29) n = 204 | 28 (26–29) n = 403 | 0.57 |
Change | ||||
Absolute, median (q1–q3) | 1 (−1 to 2) | 1 (−1 to 2) | 0 (−1 to 2) | 0.37 |
Percentage, median (q1–q3) | 3.4 (−3.4 to 7.7) n = 597 | 3.4 (−3.3 to 8.2) n = 201 | 0 (−3.4 to 7.4) n = 396 | |
P-valueb | <0.001 | <0.001 | <0.001 | |
At least mild cognitive impairment (MoCA < 26) | ||||
Baseline | 188 (30) n = 618 | 65 (32) n = 206 | 123 (30) n = 412 | 0.71 |
Follow-up | 141 (23) n = 607 | 47 (23) n = 204 | 94 (23) n = 403 | 0.99 |
P-value | <0.001 | <0.001 | <0.001 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.